FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS

Results of HOPE trial are analyzed. It is noted, that treatment with angiotensine converting enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients. The objectives and study design of ONTARGET/TRANSCEND trials are introduced. Perspectives of joint use of ACE in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Yu. M. Lopatin
Format: Artigo
Langue:Inglês
Publié: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Collection:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Sujets:
high cardio-vascular risk
ramipril
telmisartan
норе trial
ontarget trial
Accès en ligne:https://www.rpcardio.com/jour/article/view/1052
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires